Waters recently welcomed Assistant Professor Ganesh Anand's laboratory at the National University of Singapore (NUS, Queenstown, Singapore) into its Centers of Innovation Program, making the center the first of its kind in Asia.
Waters recently welcomed Assistant Professor Ganesh Anand’s laboratory at the National University of Singapore (NUS, Queenstown, Singapore) into its Centers of Innovation Program, making the center the first of its kind in Asia. The designation honors Anand and his colleagues at the Department of Biological Sciences at NUS for research into protein-protein, protein-ligand, and protein-nucleic acid interactions.
Anand, a structural biologist, is one of only a few young experts in the field of amide Hydrogen/Deuterium (H/D) exchange mass spectrometry (MS). He has been working in the field since 1999, and has authored a number of research publications on the topic. To conduct shape morphology experiments on individual proteins, Anand uses MS coupled with H/D exchange MS and ultra high performance liquid chromatography. The tools also are used in Anand’s laboratory to investigate protein-nucleic acid interactions, intrinsically disordered proteins, and the development of small-molecule inhibitors for drug discovery.
“I am grateful for Waters investments in engineering and innovation so scientists like myself can focus on answering the big scientific questions without limitations,” Anand said in a statement. “I like the academic approach taken by their scientists. They take the time to really understand scientific problems and how to address them.”
Anand is one of 13 researchers recognized through the Waters Center of Innovation program. Others include Jeremy Nicholson, Imperial College London; John Engen, Northeastern University, Boston, Massachusetts; James Scrivens, University of Warwick, Coventry, UK; David Cowan, Kings College London; Arthur Moseley, Duke University, Durham, North Carolina; Julie Leary, University of California – Davis; Albert J. Fornace, Jr., Georgetown Lombardi Comprehensive Cancer Center, Washington, D.C.; Marcos Eberlin, University of Campinas, São Paulo, Brazil; Joseph Dalluge, University of Minnesota, Duluth, Minnesota; Chang Hsu, Future Fuels Institute, Tallahassee, Florida; Konstantinos Petritis, Translational Genomics Research Institute, Phoenix, Arizona; and Vladimir Shulaev, University of North Texas Department of Biological Sciences, Denton, Texas.
The Complexity of Oligonucleotide Separations
January 9th 2025Peter Pellegrinelli, Applications Specialist at Advanced Materials Technology (AMT) explains the complexity of oligonucleotide separations due to the unique chemical properties of these molecules. Issues such as varying length, sequence complexity, and hydrophilic-hydrophobic characteristics make efficient separations difficult. Separation scientists are addressing these challenges by modifying mobile phase compositions, using varying ion-pairing reagents, and exploring alternative separation modes like HILIC and ion-exchange chromatography. Due to these complexities, AMT has introduced the HALO® OLIGO column, which offers high-resolution, fast separations through its innovative Fused-Core® technology and high pH stability. Alongside explaining the new column, Peter looks to the future of these separations and what is next to come.
Metabolomics Analysis of Low Birth-Weight Infants Using UHPLC-MS/MS Following Lipid Emulsion
January 10th 2025A recent study aimed to directly compare the changes in serum metabolites among very low birth-rate (VLBW) infants following the administration of the soybean oil-based lipid emulsion and soybean oil, medium-chain triglycerides, olive oil, and fish oil (SMOF) lipid emulsion using untargeted metabolomics techniques.
Analyzing New Drug Modalities: An ISC 2024 Interview with Kelly Zhang
January 10th 2025At ISC 2024 in Liverpool, United Kingdom, LCGC International interviewed Kelly Zhang of Genentech about her work analyzing new drug modalities, such as mRNA, oligonucleotides, peptides, and cell and gene therapies.